Mein Warenkorb

NKp46

NKp46 Molekülinformation

Englischer NameNatural cytotoxicity triggering receptor 1Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3Target-AliasNK cell-activating receptor,NK-p46,Lymphocyte antigen 94 homolog,NKp46,hNKp46,Lymphocyte Antigen 94 Homolog (Activating NK-Receptor; NK-P46),Natural killer cell p46-related protein,LY94,Lymphocyte Antigen 94 (Mouse) Homolog (Activating NK-Receptor; NK-P46),CD335 Antigen,CD335
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameNatural cytotoxicity triggering receptor 1
Target-AliasNK cell-activating receptor,NK-p46,Lymphocyte antigen 94 homolog,NKp46,hNKp46,Lymphocyte Antigen 94 Homolog (Activating NK-Receptor; NK-P46),Natural killer cell p46-related protein,LY94,Lymphocyte Antigen 94 (Mouse) Homolog (Activating NK-Receptor; NK-P46),CD335 Antigen,CD335
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

NKp46 Molekülhintergrund

Natural cytotoxicity triggering receptor 1 (NCR1) is also known as Natural killer cell p46-related protein (NK-p46), Lymphocyte antigen 94 homolog (LY94), CD antigen CD335, which belongs to the natural cytotoxicity receptor (NCR) family. NCR1 contains two Ig-like (immunoglobulin-like) domains. NCR1 interacts with CD247 and FCER1G. NCR1 / CD335 may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.

NKp46 Molekülalias

NCR1,LY94,CD335,NK-p46,hNKp46

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
NY-303NY-303Phase 2 ClinicalNAYA Biosciences IncCarcinoma, Hepatocellular; Solid tumours
Details
IPH-6501IPH-6501; IPH-65Phase 2 ClinicalInnate Pharma SALymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms
Details
SAR-443579SAR-443579; SAR443579; SAR'579; IPH6101; IPH-6101Phase 1 ClinicalSanofiBlastic Plasmacytoid Dendritic Cell Neoplasm; Hematologic Diseases; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns